Vial, J. P., Vergnolle, I., Largeaud, L., Donaty, L., Lechevalier, N., Lapierre, L., Rigolot, L., Mas, V. D., Bidet, A., Tavitian, S., Leguay, T., Borgne, E., Canali, A., Luquet, I., Klein, E., Sarry, A., Mougenot, M., Delabesse, Ã., Pigneux, A., Bertoli, S., Dumas, P. Y., Récher, C., Mimoun, A., Vergez, F. (2025). Post-induction minimal residual disease assessment by flow cytometry and molecular biology enables prognostic stratification of patients with NPM1-mutated Acute Myeloid Leukemia: A dataml registry study.. Blood. https://doi.org/10.1182/blood-2025-1744